Loading...
Loading...
Among the 8 tracked institutional investors we monitor, LYEL (LYELL IMMUNOPHARMA INC) is held with a combined value of $50.64M across 2,082,665 shares. The largest holder is VANGUARD GROUP INC with a position worth $25.44M (0.00% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter. 6 funds increased their holdings. 1 fund reduced its position.
Total Institutional Value
$50.64M
Total Shares Held
2,082,665
Institutional Holders
8
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | $25.44M | 0.00% | New |
| 2 | MILLENNIUM MANAGEMENT LLC | $9.21M | 0.00% | +682.4% |
| 3 | CITADEL ADVISORS LLC | $7.89M | 0.00% | +15.5% |
| 4 | BlackRock, Inc. | $3.85M | 0.00% | +5.5% |
| 5 | RENAISSANCE TECHNOLOGIES LLC | $2.34M | 0.00% | +194.8% |
| 6 | STATE STREET CORP | $1.45M | 0.00% | +40.9% |
| 7 | Point72 Asset Management, L.P. | $427.12K | 0.00% | +85.5% |
| 8 | FMR LLC | $36.57K | 0.00% | -0.3% |
As of the latest SEC 13F filings, VANGUARD GROUP INC is the largest institutional holder of LYEL with a position worth $25.44M, representing 0.00% of their portfolio. In total, 8 institutional investors hold LYEL with a combined value of $50.64M.
In the most recent quarter, 1 fund opened a new position in LYEL. Additionally, 6 increased their holdings and 1 reduced their positions.
Institutional investors hold $50.64M worth of LYEL stock across 8 positions. The largest institutional holder is VANGUARD GROUP INC with $25.44M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For LYEL, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their LYEL positions.